Evidence map›Paper›PMID 40869391›Full record

ArticleInternational journal of molecular sciences2025

Association of Genetically Predicted Activity of AMP Deaminase 1 with Clinical and Biochemical Parameters in Diabetic Individuals with Coronary Artery Disease.

Maria Pietrzak-Nowacka, Ewa Gątarska, Krzysztof Safranow, Agnieszka Boroń, Kazimierz Ciechanowski, Jeremy S C Clark, Andrzej Ciechanowicz, Dorota Kostrzewa-Nowak

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Pietrzak-NowackaDepartment of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0002-2698-9588
Ewa GątarskaDepartment of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.
Krzysztof SafranowDepartment of Biochemistry and Medical Chemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0001-9415-2758
Agnieszka BorońDepartment of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0003-3574-5726
Kazimierz CiechanowskiDepartment of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0003-2758-8871
Jeremy S C ClarkDepartment of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0003-3179-5638
Andrzej CiechanowiczDepartment of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0002-3804-440X
Dorota Kostrzewa-NowakDepartment of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-111 Szczecin, Poland.ORCID 0000-0001-7025-3087

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some reports indicated the association of rs17602729 and rs34526199 functional polymorphisms of the

Indexed as

AMP DeaminaseCoronary Artery DiseaseDiabetes MellitusAdultAgedAllelesCase-Control StudiesFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideAMPD1 protein, humanAMP Deaminaseadenosine monophosphate deaminase 1coronary artery diseasegene polymorphismtype 2 diabetes

Identifiers

PMID40869391
PMCPMC12386973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.